Avid Bioservices Inc (CDMO)

[biopharm]

again very interesting.... value of preclinical asset

I agree 100%

A deal like this shows immediately that the cumulative data that exists surrounding PS Targeting should allow for a much higher market cap at this point vs the current market cap.

Although we already knew that..... but now, it is much easier to argue and dismiss, EVER, the possibility of ever having to do any reverse split or maybe Mr. Dart will move closer to 48% ownership via some upcoming preferred shares and once all those preferred are converted to common

close to 50% PPHM ownership